Annual report pursuant to Section 13 and 15(d)

Note 3 - Revenue (Tables)

v3.24.1
Note 3 - Revenue (Tables)
12 Months Ended
Dec. 31, 2023
Notes Tables  
Disaggregation of Revenue [Table Text Block]
   

Year Ended December 31,

 
   

2023

   

2022

 

AstraZeneca

  $ 8,399     $ 9,117  

Pfizer

    15,134       8,287  

Servier

    4,099       5,359  

Genentech

    12,697       3,139  

Boston Pharmaceuticals

    2,481        

Total Revenue

  $ 42,810     $ 25,902  
Revenue From Contract With Customer, Milestone Payments [Table Text Block]
   

Research, Development, Regulatory & Commercial Milestones

   

Sales Milestones

 

Pfizer

  $ 759     $ 450  

Servier

    107       99  

Boston Pharmaceuticals

    85       265  

Total potential milestone payments

  $ 951     $ 814